Arkolith/Insider Trading/PTGX/Form 4

Patel Dinesh V PH D

President and CEO, DirectorProtagonist Therapeutics, Inc (PTGX) · full profile →Form 4 · filed Mar 25, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5.5M
Net Open-Market Flow
-$5.5M
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 25, 2026Sell(S)55K$101.00$5.5M525K
Mar 25, 2026Option exercise(M)55K$8.58$469K580K
Mar 24, 2026Option exercise(M)59$8.58$506525K
Mar 24, 2026Sell(S)59$101.00$6K525K
Mar 23, 2026Gift(G)50K—$0525K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 25, 2026Option exercise(M)55K—$00
Mar 24, 2026Option exercise(M)59—$055K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-034736) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML